Open Access 01-12-2017 | Research
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Published in: Journal of Hematology & Oncology | Issue 1/2017
Login to get access